Clinical Trials Logo

Mycosis Fungoides clinical trials

View clinical trials related to Mycosis Fungoides.

Filter by:

NCT ID: NCT00005788 Terminated - Lymphoma Clinical Trials

Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Start date: April 1997
Phase: Phase 2
Study type: Interventional

RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill lymphoma cells. PURPOSE: Phase II trial to study the effectiveness of interleukin-2 in treating patients who have mycosis fungoides or Sezary syndrome.

NCT ID: NCT00004106 Terminated - Lymphoma Clinical Trials

Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Start date: May 1998
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying temozolomide to see how well it works in treating patients with mycosis fungoides or Sezary syndrome that has not responded to previous treatment.